Member Articles

Update: Frequently Asked Questions About Valuentum Securities, Inc.

by

What is Valuentum Securities? Valuentum (val∙u∙n∙tum) [val-yoo-en-tuh-m] Securities Inc. is an independent investment research publisher, offering premium equity reports and dividend reports, as well as commentary across all sectors/companies, a Best Ideas Newsletter (spanning market caps, asset classes), a Dividend Growth Newsletter, modeling tools/products, and more. Independence and integrity remain our core, and we strive to be a champion of the investor. Valuentum is based in the Chicagoland area. Valuentum is not a money manager, broker, or financial advisor. Valuentum is a publisher of financial information. How do I subscribe to Valuentum’s investment research services? 1)    Click the following link: signup-page. 2)    Select your membership plan. 3)    Enter your contact details. 4)    Click ‘Sign Up.’ 5)    Complete your purchase. 6)   Your payment profile may be recurring, so please check … Read more

January 5-9: The Week That Was – Drowning in Crude

by

By Brian Nelson, CFA The first full week of 2015 was a wild one! Monday and Tuesday brought some hefty losses to the indices, but the middle of the week helped recover most of the ground, only to give some of it back Friday. When all was said and done, however, the S&P 500 still closed comfortably above 2040, a huge leap from just 5-6 years ago. We’re still enjoying the good times, with economic data still coming in relatively sanguine. Like a frog in water, the markets are just waiting for the next shoe to drop, and the Federal Reserve is doing all that it can to assure investors that the Yellen-put is there to prop up the markets should … Read more

Consumer Staples: Product Pricing Gains To Wane in 2017?

by

Consumer staples giants Kimberly-Clark and Colgate-Palmolive are expecting product pricing growth to be less of a contributor in 2017. We think investors are wising up to the risks of consumer staples stocks, and increasing risk-free rates seem to already be complicating the investment decision-making process for many investors. Consumer staples equities in the S&P 500 are currently trading at ~19.4 times forward 12-month earnings, well above their sub-17 times 10-year trailing average. We believe investors will continue to swap out of these steady-eddy, but overpriced, gems in the near term, in favor of higher-beta commodity and energy-oriented companies as the market sets up to surge in 2017. We have been warning about the tipping point in Treasury yields and implications … Read more

How the FDA’s Delay of Baricitinib Impacts Eli Lilly and Incyte

by

Image Source: Paul Sableman The FDA dealt Eli Lilly and Incyte an unforeseen blow recently by rejecting their marketing application for Rheumatoid Arthritis candidate Baricitinib. Where does the duo go from here? By Alexander J. Poulos an Kris Rosemann The drug approval process is chock full of pitfalls, and until regulators give the final okay, anything can happen. The widely held consensus was Eli Lilly’s (LLY) and Incyte’s (INCY) marketing application for Rheumatoid Arthritis candidate Baricitinib would be approved, but the FDA shocked everyone by issuing a complete response letter requesting further data. Where does the duo of Eli Lilly and Incyte proceed from here? Baricitinib We were optimistic the FDA would approve Baricitinib for the indication of Rheumatoid Arthritis … Read more

Dividend Increases/Decreases for the Week Ending November 17

by

Below we provide a list of firms that raised/lowered their dividends during the week ending November 17. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header. Firms Raising Their Dividends This Week Agilent (A): now $0.149 per share quarterly dividend, was $0.132. American Equity (AEL): now $0.26 per share annual dividend, was $0.24. AmerisourceBergen (ABC): now $0.38 per share quarterly dividend, was $0.365. Aramark (ARMK): now $0.105 per share quarterly dividend, was $0.103. Bancroft Fund (BCV): now $0.41 per share quarterly dividend, was $0.25. Black Hills (BKH): now $0.475 per share quarterly dividend, was $0.445. Brown-Forman (BF.B): now … Read more

In The News: APU, EPD, MMP, OHI, PSA, O, TGE

by

We’re keeping a close eye on a number of high-yielding equities, and several have reported strong earnings during the calendar second quarter. By Kris Rosemann AmeriGas Partners Raises Adjusted EBITDA Guidance AmeriGas Partners (APU), the country’s largest retail propane marketer, turned in its best fiscal third quarter adjusted EBITDA performance since fiscal 2013 in the quarter ended June 30, 2018, results released August 1. Adjusted EBITDA advanced 15% from the year-ago period, and management subsequently raised its full-year fiscal 2018 EBITDA guidance to $625-$645 million from $610-$620 million. Retail volumes sold grew 4% in the quarter thanks to colder weather in April, which was partially offset by warmer months in May and June compared to the same period of fiscal … Read more

Top-Weighted Visa Leaps to Mid-$160s, More Earnings Reports

by

Top-Weighted Visa Leaps to Mid-$160s, More Reports Image: Visa (V) has been the top-weighted idea in the Best Ideas Newsletter for as long as we can remember. In December 2017, when we migrated to weighting ranges for ideas in the newsletter portfolio, the company’s “weight” was 8.6%. The image above shows its performance relative to the S&P 500 (SPY) since then. Source (pdf). — In alphabetical order by ticker symbol: GOOG, LLY, GE, GM, IR, LL, MA, MCD, MRK, PFE, TXRH, WDC — Alphabet (GOOG, GOOGL): Shares of Alphabet, the parent of Google, reported first-quarter performance April 29 that may have revealed weakness in the revenue story at the search giant. The miss was rather large on the top line during the quarter, but … Read more

Vodafone’s Dividend Cut, Alibaba’s Resilience, More Reports

by

Vodafone’s Dividend Cut, Alibaba’s Resilience, More Reports In alphabetical order by company name: A, BABA, PLCE, GES, M, NSANY, RL, TLRY, VOD — Good morning, — Still buying stocks immediately as they fall and on the way down? There may be no logical basis for doing so. Here’s an excerpt from Value Trap: Theory of Universal Valuation.  — Image: Excerpt from Value Trap, page 241 — Order your copy here.  — The market must eventually agree with you for your idea to work out, so why not wait until the stock starts to move higher first. Waiting a few weeks or a few months/quarters to see if the stock eventually settles and technical/momentum indicators start to improve is vital in helping … Read more